Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267982 · ClinicalTrials.gov registry record
Radiofrequency Ablation of Ectopic Atrial Tachycardia
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 25
- Enrollment target
NCT00267982 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 25 participants.
The verdict
NCT00267982 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
A retrospective chart review will be performed on 50 patients who received RFA for the treatment of EAT between August 1992 and August 2003 at Children's Healthcare of Atlanta. The use of the CARTO/Biosense catheter has improved outcomes with decreased radiation exposure to patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 1992-08 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00267982
The ClinicalTrials.gov registry entry for NCT00267982 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00267982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00267982 about?
NCT00267982 is a clinical study titled "Radiofrequency Ablation of Ectopic Atrial Tachycardia". A retrospective chart review will be performed on 50 patients who received RFA for the treatment of EAT between August 1992 and August 2003 at Children's Healthcare of Atlanta. The use of the CARTO/Biosense catheter has improved outcomes with decreased radiation exposure to patients.
What is the current status of trial NCT00267982?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 1992-08. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00267982?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.